Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Leases (2019 - 2025)

Corbus Pharmaceuticals Holdings has reported Leases over the past 7 years, most recently at $3.1 million for Q4 2023.

  • For Q4 2023, Leases fell 21.14% year-over-year to $3.1 million; the TTM value through Dec 2023 reached $3.1 million, down 21.14%, while the annual FY2023 figure was $3.1 million, 21.14% down from the prior year.
  • Leases for Q4 2023 was $3.1 million at Corbus Pharmaceuticals Holdings, down from $3.3 million in the prior quarter.
  • Over five years, Leases peaked at $5.8 million in Q1 2019 and troughed at $3.1 million in Q4 2023.
  • A 5-year average of $4.7 million and a median of $4.9 million in 2021 define the central range for Leases.
  • Biggest five-year swings in Leases: fell 2.72% in 2020 and later fell 21.14% in 2023.
  • Year by year, Leases stood at $5.8 million in 2019, then decreased by 9.8% to $5.2 million in 2020, then decreased by 12.18% to $4.6 million in 2021, then decreased by 15.73% to $3.9 million in 2022, then fell by 21.14% to $3.1 million in 2023.
  • Business Quant data shows Leases for CRBP at $3.1 million in Q4 2023, $3.3 million in Q3 2023, and $3.5 million in Q2 2023.